Patients with Huntington’s disease exhibit memory and cognitive deficits many years before manifesting motor disturbances. Similarly, several studies have shown that deficits in long-term synaptic plasticity, a cellular basis of memory formation and storage, occur well before motor disturbances in the hippocampus of the transgenic mouse models of Huntington’s disease. The autosomal dominant inheritance pattern of Huntington’s disease suggests the importance of the mutant protein, huntingtin, in pathogenesis of Huntington’s disease, but wild type huntingtin also has been shown to be important for neuronal functions such as axonal transport. Yet, the role of wild type huntingtin in long-term synaptic plasticity has not been investigated in detail. We identified a huntingtin homolog in the marine snail Aplysia, and find that similar to the expression pattern in mammalian brain, huntingtin is widely expressed in neurons and glial cells. Importantly the expression of mRNAs of huntingtin is upregulated by repeated applications of serotonin, a modulatory transmitter released during learning in Aplysia. Furthermore, we find that huntingtin expression levels are critical, not only in presynaptic sensory neurons, but also in the postsynaptic motor neurons for serotonin-induced long-term facilitation at the sensory-to-motor neuron synapse of the Aplysia gill-withdrawal reflex. These results suggest a key role for huntingtin in long-term memory storage.
References
[1]
Ross CA, Tabrizi SJ (2011) Huntington’s disease: from molecular pathogenesis to clinical treatment. Lancet neurology 10: 83–98. doi: 10.1016/s1474-4422(10)70245-3
[2]
Paulsen JS (2011) Cognitive impairment in Huntington disease: diagnosis and treatment. Current neurology and neuroscience reports 11: 474–483. doi: 10.1007/s11910-011-0215-x
[3]
Giralt A, Puigdellivol M, Carreton O, Paoletti P, Valero J, et al. (2012) Long-term memory deficits in Huntington’s disease are associated with reduced CBP histone acetylase activity. Human molecular genetics 21: 1203–1216. doi: 10.1093/hmg/ddr552
[4]
Orth M, European Huntington’s Disease N, Handley OJ, Schwenke C, Dunnett S, et al. (2011) Observing Huntington’s disease: the European Huntington’s Disease Network’s REGISTRY. Journal of neurology, neurosurgery, and psychiatry 82: 1409–1412. doi: 10.1136/jnnp.2010.209668
[5]
Schippling S, Schneider SA, Bhatia KP, Munchau A, Rothwell JC, et al. (2009) Abnormal motor cortex excitability in preclinical and very early Huntington’s disease. Biological psychiatry 65: 959–965. doi: 10.1016/j.biopsych.2008.12.026
[6]
Lynch G, Kramar EA, Rex CS, Jia Y, Chappas D, et al. (2007) Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington’s disease. The Journal of neuroscience: the official journal of the Society for Neuroscience 27: 4424–4434. doi: 10.1523/jneurosci.5113-06.2007
[7]
Murphy KP, Carter RJ, Lione LA, Mangiarini L, Mahal A, et al. (2000) Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington’s disease mutation. The Journal of neuroscience: the official journal of the Society for Neuroscience 20: 5115–5123.
[8]
Usdin MT, Shelbourne PF, Myers RM, Madison DV (1999) Impaired synaptic plasticity in mice carrying the Huntington’s disease mutation. Human molecular genetics 8: 839–846. doi: 10.1093/hmg/8.5.839
[9]
Milnerwood AJ, Cummings DM, Dallerac GM, Brown JY, Vatsavayai SC, et al. (2006) Early development of aberrant synaptic plasticity in a mouse model of Huntington’s disease. Human molecular genetics 15: 1690–1703. doi: 10.1093/hmg/ddl092
[10]
Cattaneo E, Rigamonti D, Goffredo D, Zuccato C, Squitieri F, et al. (2001) Loss of normal huntingtin function: new developments in Huntington’s disease research. Trends in neurosciences 24: 182–188. doi: 10.1016/s0166-2236(00)01721-5
[11]
Harjes P, Wanker EE (2003) The hunt for huntingtin function: interaction partners tell many different stories. Trends in biochemical sciences 28: 425–433. doi: 10.1016/s0968-0004(03)00168-3
[12]
Cattaneo E, Zuccato C, Tartari M (2005) Normal huntingtin function: an alternative approach to Huntington’s disease. Nature reviews Neuroscience 6: 919–930. doi: 10.1038/nrn1806
[13]
Rigamonti D, Bauer JH, De-Fraja C, Conti L, Sipione S, et al. (2000) Wild-type huntingtin protects from apoptosis upstream of caspase-3. The Journal of neuroscience: the official journal of the Society for Neuroscience 20: 3705–3713.
[14]
Leavitt BR, Guttman JA, Hodgson JG, Kimel GH, Singaraja R, et al. (2001) Wild-type huntingtin reduces the cellular toxicity of mutant huntingtin in vivo. American journal of human genetics 68: 313–324. doi: 10.1086/318207
[15]
Zhang Y, Li M, Drozda M, Chen M, Ren S, et al. (2003) Depletion of wild-type huntingtin in mouse models of neurologic diseases. Journal of neurochemistry 87: 101–106. doi: 10.1046/j.1471-4159.2003.01980.x
[16]
Dragatsis I, Levine MS, Zeitlin S (2000) Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice. Nature genetics 26: 300–306.
[17]
Nasir J, Floresco SB, O’Kusky JR, Diewert VM, Richman JM, et al. (1995) Targeted disruption of the Huntington’s disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 81: 811–823. doi: 10.1016/0092-8674(95)90542-1
[18]
Duyao MP, Auerbach AB, Ryan A, Persichetti F, Barnes GT, et al. (1995) Inactivation of the mouse Huntington’s disease gene homolog Hdh. Science 269: 407–410. doi: 10.1126/science.7618107
[19]
Zeitlin S, Liu JP, Chapman DL, Papaioannou VE, Efstratiadis A (1995) Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington’s disease gene homologue. Nature genetics 11: 155–163. doi: 10.1038/ng1095-155
[20]
MacDonald ME (2003) Huntingtin: alive and well and working in middle management. Science’s STKE: signal transduction knowledge environment 2003: pe48. doi: 10.1126/scisignal.2072003pe48
[21]
Sun Y, Savanenin A, Reddy PH, Liu YF (2001) Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-D-aspartate receptors via post-synaptic density 95. The Journal of biological chemistry 276: 24713–24718. doi: 10.1074/jbc.m103501200
[22]
DiFiglia M, Sapp E, Chase K, Schwarz C, Meloni A, et al. (1995) Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 14: 1075–1081. doi: 10.1016/0896-6273(95)90346-1
[23]
Velier J, Kim M, Schwarz C, Kim TW, Sapp E, et al. (1998) Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways. Experimental neurology 152: 34–40. doi: 10.1006/exnr.1998.6832
[24]
Hilditch-Maguire P, Trettel F, Passani LA, Auerbach A, Persichetti F, et al. (2000) Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles. Human molecular genetics 9: 2789–2797. doi: 10.1093/hmg/9.19.2789
[25]
Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, et al. (2001) Loss of huntingtin-mediated BDNF gene transcription in Huntington’s disease. Science 293: 493–498. doi: 10.1126/science.1059581
[26]
Zuccato C, Tartari M, Crotti A, Goffredo D, Valenza M, et al. (2003) Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nature genetics 35: 76–83. doi: 10.1038/ng1219
[27]
Gauthier LR, Charrin BC, Borrell-Pages M, Dompierre JP, Rangone H, et al. (2004) Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118: 127–138. doi: 10.1016/j.cell.2004.06.018
[28]
Gunawardena S, Her LS, Brusch RG, Laymon RA, Niesman IR, et al. (2003) Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila. Neuron 40: 25–40. doi: 10.1016/s0896-6273(03)00594-4
[29]
Gunawardena S, Goldstein LS (2001) Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila. Neuron 32: 389–401. doi: 10.1016/s0896-6273(01)00496-2
[30]
Bowman AB, Kamal A, Ritchings BW, Philp AV, McGrail M, et al. (2000) Kinesin-dependent axonal transport is mediated by the sunday driver (SYD) protein. Cell 103: 583–594. doi: 10.1016/s0092-8674(00)00162-8
[31]
McGuire JR, Rong J, Li SH, Li XJ (2006) Interaction of Huntingtin-associated protein-1 with kinesin light chain: implications in intracellular trafficking in neurons. The Journal of biological chemistry 281: 3552–3559. doi: 10.1074/jbc.m509806200
[32]
Marinesco S, Wickremasinghe N, Carew TJ (2006) Regulation of behavioral and synaptic plasticity by serotonin release within local modulatory fields in the CNS of Aplysia. The Journal of neuroscience: the official journal of the Society for Neuroscience 26: 12682–12693. doi: 10.1523/jneurosci.3309-06.2006
[33]
Montarolo PG, Goelet P, Castellucci VF, Morgan J, Kandel ER, et al. (1986) A critical period for macromolecular synthesis in long-term heterosynaptic facilitation in Aplysia. Science 234: 1249–1254. doi: 10.1126/science.3775383
[34]
Bailey CH, Chen M (1988) Long-term memory in Aplysia modulates the total number of varicosities of single identified sensory neurons. Proceedings of the National Academy of Sciences of the United States of America 85: 2373–2377. doi: 10.1073/pnas.85.7.2373
[35]
Kandel ER (2001) The molecular biology of memory storage: a dialogue between genes and synapses. Science 294: 1030–1038. doi: 10.1126/science.1067020
[36]
Lee JA, Lim CS, Lee SH, Kim H, Nukina N, et al. (2003) Aggregate formation and the impairment of long-term synaptic facilitation by ectopic expression of mutant huntingtin in Aplysia neurons. Journal of neurochemistry 85: 160–169. doi: 10.1046/j.1471-4159.2003.01650.x
[37]
Li Z, Karlovich CA, Fish MP, Scott MP, Myers RM (1999) A putative Drosophila homolog of the Huntington’s disease gene. Human molecular genetics 8: 1807–1815. doi: 10.1093/hmg/8.9.1807
[38]
Karlovich CA, John RM, Ramirez L, Stainier DY, Myers RM (1998) Characterization of the Huntington’s disease (HD) gene homologue in the zebrafish Danio rerio. Gene 217: 117–125. doi: 10.1016/s0378-1119(98)00342-4
[39]
Rockabrand E, Slepko N, Pantalone A, Nukala VN, Kazantsev A, et al. (2007) The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis. Human molecular genetics 16: 61–77. doi: 10.1093/hmg/ddl440
[40]
Andrade MA, Bork P (1995) HEAT repeats in the Huntington’s disease protein. Nature genetics 11: 115–116. doi: 10.1038/ng1095-115
[41]
Puthanveettil SV, Monje FJ, Miniaci MC, Choi YB, Karl KA, et al. (2008) A new component in synaptic plasticity: upregulation of kinesin in the neurons of the gill-withdrawal reflex. Cell 135: 960–973. doi: 10.1016/j.cell.2008.11.003
[42]
Alberini CM, Ghirardi M, Metz R, Kandel ER (1994) C/EBP is an immediate-early gene required for the consolidation of long-term facilitation in Aplysia. Cell 76: 1099–1114. doi: 10.1016/0092-8674(94)90386-7
[43]
Marsh JL, Pallos J, Thompson LM (2003) Fly models of Huntington’s disease. Human molecular genetics 12 Spec No 2: R187–193. doi: 10.1093/hmg/ddg271
[44]
Flinn L, Bretaud S, Lo C, Ingham PW, Bandmann O (2008) Zebrafish as a new animal model for movement disorders. Journal of neurochemistry 106: 1991–1997. doi: 10.1111/j.1471-4159.2008.05463.x
[45]
Pouladi MA, Morton AJ, Hayden MR (2013) Choosing an animal model for the study of Huntington’s disease. Nature reviews Neuroscience 14: 708–721. doi: 10.1038/nrn3570
[46]
Ehrnhoefer DE, Butland SL, Pouladi MA, Hayden MR (2009) Mouse models of Huntington disease: variations on a theme. Disease models & mechanisms 2: 123–129. doi: 10.1242/dmm.002451
[47]
Tong Y, Ha TJ, Liu L, Nishimoto A, Reiner A, et al. (2011) Spatial and temporal requirements for huntingtin (Htt) in neuronal migration and survival during brain development. The Journal of neuroscience: the official journal of the Society for Neuroscience 31: 14794–14799. doi: 10.1523/jneurosci.2774-11.2011
[48]
Kordasiewicz HB, Stanek LM, Wancewicz EV, Mazur C, McAlonis MM, et al. (2012) Sustained therapeutic reversal of Huntington’s disease by transient repression of huntingtin synthesis. Neuron 74: 1031–1044. doi: 10.1016/j.neuron.2012.05.009
[49]
Giustetto M, Hegde AN, Si K, Casadio A, Inokuchi K, et al. (2003) Axonal transport of eukaryotic translation elongation factor 1alpha mRNA couples transcription in the nucleus to long-term facilitation at the synapse. Proceedings of the National Academy of Sciences of the United States of America 100: 13680–13685. doi: 10.1073/pnas.1835674100
[50]
Choi YB, Li HL, Kassabov SR, Jin I, Puthanveettil SV, et al. (2011) Neurexin-neuroligin transsynaptic interaction mediates learning-related synaptic remodeling and long-term facilitation in aplysia. Neuron 70: 468–481. doi: 10.1016/j.neuron.2011.03.020
[51]
Diekmann H, Anichtchik O, Fleming A, Futter M, Goldsmith P, et al. (2009) Decreased BDNF levels are a major contributor to the embryonic phenotype of huntingtin knockdown zebrafish. The Journal of neuroscience: the official journal of the Society for Neuroscience 29: 1343–1349. doi: 10.1523/jneurosci.6039-08.2009
[52]
Chao MV (2003) Neurotrophins and their receptors: a convergence point for many signalling pathways. Nature reviews Neuroscience 4: 299–309. doi: 10.1038/nrn1078
[53]
Kassabov SR, Choi YB, Karl KA, Vishwasrao HD, Bailey CH, et al. (2013) A single Aplysia neurotrophin mediates synaptic facilitation via differentially processed isoforms. Cell reports 3: 1213–1227. doi: 10.1016/j.celrep.2013.03.008
[54]
Steffan JS, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu YZ, et al. (2000) The Huntington’s disease protein interacts with p53 and CREB-binding protein and represses transcription. Proceedings of the National Academy of Sciences of the United States of America 97: 6763–6768. doi: 10.1073/pnas.100110097
